Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

Presentation TCT 2014

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Presenter: Gregory Wilson

September 16, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

Advertisement

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Top Endovascular News of 2023

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content